API
< Back to all clusters
[BUSINESS] · India · 7 sources

started · updated

India NPPA mandates strict monitoring of 137 anti-cancer drug prices

The National Pharmaceutical Pricing Authority (NPPA) has ordered strict monitoring of trade margin rationalisation for 137 non-scheduled anti-cancer drugs. This follows a gazette order issued in October 2026 that capped trade margins at 30 per cent to reduce costs for patients. The revised pricing structure officially came into effect on November 9, 2026.

All manufacturers, stockists, dealers, retailers, and medical institutions are required to comply with the new prices and must prominently display updated price lists at their physical premises and on their websites. State Drug Controllers (SDCs) have been instructed to monitor the entire supply chain to ensure the benefits of the lower maximum retail prices (MRPs) reach patients. SDCs must submit action taken reports to the NPPA by November 16, 2026.

Violations of these directives may result in overcharging proceedings under the provisions of the Drugs (Price Control) Order (DPCO), 2013. The NPPA has provided several channels for reporting overcharging, shortages, or medicine unavailability, including the Pharma Sahi Daam app, a dedicated helpline, and email.

Entities

Department of Pharmaceuticals · India · National Pharmaceutical Pricing Authority